Hypotension Prediction Index (HPI) in Patients Undergoing Robotic Assisted Radical Prostatectomy
HPI in RARP
1 other identifier
interventional
80
1 country
1
Brief Summary
Robot assisted radical prostatectomy (RARP) is the leader in robotic treatment for prostate cancer. Goal-directed therapy (GDT) is the approach used, but HPI, a machine learning algorithm analysing arterial waveforms, might offer additional benefits. The aim of this prospective randomised study is to evaluate the cumulative amount of intraoperative arterial hypotension episodes in patients undergoing RARP managed by GDT protocol guided or not by HPI algorithm
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2023
CompletedFirst Submitted
Initial submission to the registry
July 30, 2024
CompletedFirst Posted
Study publicly available on registry
August 2, 2024
CompletedAugust 2, 2024
July 1, 2024
1.3 years
July 30, 2024
July 30, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
cumulative amount of time spent in Hypotension
the cumulative amount of intraoperative hypotension, measured by Time Weighted Average (TWA) of Mean Arterial Pressure (MAP) below 65 mmHg
intraoperative
Study Arms (2)
Goal-directed therapy guided by Hypotension Prediction Index algorithm
ACTIVE COMPARATORGoal-directed therapy alone
SHAM COMPARATORInterventions
Fluid management guided by Hypotension Prediction Index
Fluid management not guided by Hypotension Prediction Index
Eligibility Criteria
You may qualify if:
- all consecutive patients undergoing RARP; American Society of Anaesthesiology (ASA) SCORE I-III
You may not qualify if:
- Body Mass Index (BMI) of 18.5 to 35, uncontrolled arrhythmias, myocardial infarction or ischemic/hemorrhagic stroke in the last 6 months, III/IV stage Global Initiative for Chronic Obstructive Lung Disease, pulmonary fibrosis, contraindication to radial artery cannulation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ospedali Riuniti
Foggia, Apulia, 71100, Italy
Related Publications (1)
Cotoia A, Discenza A, Rauseo M, Matella M, Caggianelli G, Ciaramelletti R, Mirabella L, Cinnella G. Intraoperative hypotension during robotic-assisted radical prostatectomy: A randomised controlled trial comparing standard goal-directed fluid therapy with hypotension prediction index-guided goal-directed fluid therapy. Eur J Anaesthesiol. 2025 Oct 1;42(10):916-923. doi: 10.1097/EJA.0000000000002211. Epub 2025 Jun 9.
PMID: 40493027DERIVED
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof
Study Record Dates
First Submitted
July 30, 2024
First Posted
August 2, 2024
Study Start
January 1, 2022
Primary Completion
April 30, 2023
Study Completion
September 1, 2023
Last Updated
August 2, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share
It is not allowed in the consent form